Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT03121079
What this trial is testing

Interferon-α Prevents Leukemia Relapse of AML Patients After Transplantation

Who this might be right for
Interferon-A-2BRelapsePrevention+1 more
Peking University People's Hospital
Early research (Phase 1)Active Not RecruitingNCT03560752
What this trial is testing

CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant

Who this might be right for
Accelerated Phase CML, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 34
Early research (Phase 1)Study completedNCT00890747
What this trial is testing

Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Undifferentiated Leukemia+82 more
National Cancer Institute (NCI) 42
Not applicableUnknownNCT03272789
What this trial is testing

Onco-coaching of Sport-inspired for the Social, Professional and Psychological Restoring of the Patients in Cancer Remission After Allogeneic Transplantation of Hematopoietic Stem Cells

Who this might be right for
Haematologic Disease (Cancer)Onco-coaching of Sport- Inspirated
Institut Paoli-Calmettes 32
Early research (Phase 1)Study completedNCT00078533
What this trial is testing

Cytotoxic T-Lymphocytes for the Prophylaxis of Cytomegalovirus After Allogeneic Stem Cell Transplant

Who this might be right for
Cytomegalovirus Infections
Baylor College of Medicine 26
Early research (Phase 1)Study completedNCT03600155
What this trial is testing

Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia+1 more
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00369226
What this trial is testing

Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Dana-Farber Cancer Institute 45
Not applicableLooking for participantsNCT06692868
What this trial is testing

Fertility Protection for Children, Adolescents and Young Adults

Who this might be right for
Stem Cell TransplantStem Cell TransplantationOncological Outcomes+8 more
University of Ulm 2,000
Testing effectiveness (Phase 2)Looking for participantsNCT07185633
What this trial is testing

Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease

Who this might be right for
aGVHD
Bin Gu 25
Testing effectiveness (Phase 2)UnknownNCT04958538
What this trial is testing

MTX and Steroid for III-IV aGVHD Treatment

Who this might be right for
Acute Graft Versus Host Disease
Peking University People's Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07387848
What this trial is testing

Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas

Who this might be right for
Diffuse Large B Cell Lymphoma Refractory
American University of Beirut Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT01280955
What this trial is testing

Donor Enhancement With Plerixafor Post Myeloablative Allogeneic Transplant

Who this might be right for
Failure of Bone Marrow Graft
Mitchell Horwitz, MD 41
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Not applicableUnknownNCT05087784
What this trial is testing

AlloLife - Life After Transplantation

Who this might be right for
SurvivorshipStem Cell Transplant Complications
University Hospital, Essen 192
Early research (Phase 1)Study completedNCT01129193
What this trial is testing

AR-42 in Treating Patients With Advanced or Relapsed Multiple Myeloma, Chronic Lymphocytic Leukemia, or Lymphoma

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+64 more
Amir Mortazavi 44
Testing effectiveness (Phase 2)Study completedNCT02294552
What this trial is testing

Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaLymphoma+3 more
Ivan S Moiseev 200
Large-scale testing (Phase 3)Study completedNCT02673008
What this trial is testing

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

Who this might be right for
Minimal Residual DiseaseDonor Lymphocyte InfusionHematopoietic Stem Cell Transplantation+1 more
Nanfang Hospital, Southern Medical University 206
Early research (Phase 1)Study completedNCT02917096
What this trial is testing

Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis

Who this might be right for
Primary MyelofibrosisSecondary Myelofibrosis
City of Hope Medical Center 18
Testing effectiveness (Phase 2)UnknownNCT02632396
What this trial is testing

Ixazomib & Rituximab After Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma in Remission

Who this might be right for
Mantle Cell Lymphoma
Emory University 12
Not applicableUnknownNCT03294824
What this trial is testing

Non Randomized Comparative Study With Control

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Assistance Publique - Hôpitaux de Paris 90
Next Page